Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances with RNA interference in Alzheimer's disease research.

Drug design, development and therapy - 1 Jan 2013

Chen Shun, Ge Xuemei, Chen Yinghui, Lv Nan, Liu Zhenguo, Yuan Weien

Abstract excerpt

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized clinically by memory and cognitive dysfunction. Unfortunately, there is no effective therapeutic method for AD treatment or ways to halt disease progression. Many mechanisms are involved in the disease, including genes mutation and protein dysfunction. RNA interference (RNAi) technology may potentially be able to control AD. It can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Base Sequence
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mutation

Share to RNA Interference

Share to RNA, Small Interfering

Source

Open in PubMed Open full text

Identifiers

PMID: 23459401
DOI: 10.2147/DDDT.S40229
PMCID: PMC3582316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances with RNA interference in Alzheimer's disease research.PMID 23459401Read ↗

miRNAs as Therapeutic Tools in Alzheimer’s DiseaseSemantic proximity Read ↗

The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.Semantic proximity Read ↗

MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapySemantic proximity Read ↗

Role of miRNAs in Alzheimer’s Disease and Possible Fields of ApplicationSemantic proximity Read ↗

The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic PotentialsSemantic proximity Read ↗

A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicineSemantic proximity Read ↗

MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNA Dysregulation in Alzheimer's DiseaseSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic BiomarkersSemantic proximity Read ↗

The Regulation of microRNAs in Alzheimer's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.